OPANA ER (OXYMORPHONE HYDROCHLORIDE) — FDA Approval NDA021610 (ENDO OPERATIONS)
OPANA ER (OXYMORPHONE HYDROCHLORIDE) — FDA Approval NDA021610 (ENDO OPERATIONS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: OPANA ER; Active ingredients: OXYMORPHONE HYDROCHLORIDE; Application number: NDA021610.
| Brand name | OPANA ER |
|---|---|
| Active ingredients | OXYMORPHONE HYDROCHLORIDE |
| Application number | NDA021610 |
| Sponsor | ENDO OPERATIONS |
| Dosage form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 7 |
| First approval date | 20060622 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →